← Back to Clinical Trials
Recruiting NCT06896032

NCT06896032 Retro-walking Versus Forward-walking Training Using Underwater Treadmill in Patients With Knee Osteoarthritis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06896032
Status Recruiting
Phase
Sponsor Nourhan Atwa Said
Condition Knee Osteoarthritis (Knee OA)
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-03-30
Primary Completion 2025-06-30

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
physical therapy intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-03-30 with a primary completion date of 2025-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study Will investigate and compare the effects of retro-walking and forward-walking underwater treadmill training on pain, function and ROM in subjects with chronic knee OA

Eligibility Criteria

Inclusion Criteria: 1. 60 patients with chronic knee OA. 2. Age ranges from 40-60 years old of both genders. 3. body mass index (BMI) 25- 35kg/m2. 4. The degree of osteoarthritis was mild or moderate and have a Kellgren- Lawrence radiographic grade of of1-3. 5. unilateral knee osteoarthritis involvement. Exclusion Criteria: 1. hydrophobia. 2. pregnancy. 3. infection. 4. psychiatric disorder. 5. haemorrhagic diathesis. 6. cardiac pacemaker. 7. all Subjects with deformity of hip, knee \& ankle. 8. any CNS or PNS involvement. 9. recent steroidal or intraarticular injections (3 months). 10. systemic inflammatory disease and bone malignancy.

Contact & Investigator

Central Contact

nourhan atwa said, bacalora

✉ nourhan.atwa@icloud.com

📞 +201005074315

Frequently Asked Questions

Who can join the NCT06896032 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Knee Osteoarthritis (Knee OA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06896032 currently recruiting?

Yes, NCT06896032 is actively recruiting participants. Contact the research team at nourhan.atwa@icloud.com for enrollment information.

Where is the NCT06896032 trial being conducted?

This trial is being conducted at Cairo, Egypt, Cairo, Egypt.

Who is sponsoring the NCT06896032 clinical trial?

NCT06896032 is sponsored by Nourhan Atwa Said. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology